RAI - Chesapeake-Newport News is a medicare approved dialysis facility center in Newport News, Virginia and it has 10 dialysis stations. It is located in Newport News City county at 225 Chesapeake Avenue, Newport News, VA, 23607. You can reach out to the office of RAI - Chesapeake-Newport News at (757) 247-4080. This dialysis clinic is managed and/or owned by Fresenius Medical Care. RAI - Chesapeake-Newport News has the following ownership type - Profit. It was first certified by medicare in July, 2006. The medicare id for this facility is 492645 and it accepts patients under medicare ESRD program.
| Name | RAI - Chesapeake-Newport News |
|---|---|
| Location | 225 Chesapeake Avenue, Newport News, Virginia |
| No. of Dialysis Stations | 10 |
| Medicare ID | 492645 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 225 Chesapeake Avenue, Newport News, Virginia, 23607 | |
| (757) 247-4080 | |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
New research indicates that harm from medicines is common in older adults following hospital discharge, and it results in substantial use of healthcare resources.
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
› Verified 5 days ago
| NPI Number | 1831121060 |
| Organization Name | Rai-main Street-newport News |
| Doing Business As | Rai Care Centers Of Virginia I, Llc |
| Address | 314 Main St Newport News, Virginia, 23601 |
| Phone Number | (757) 594-5535 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
New research indicates that harm from medicines is common in older adults following hospital discharge, and it results in substantial use of healthcare resources.
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
› Verified 5 days ago
| NPI Number | 1861424947 |
| Organization Name | Rai-chesapeake Ave.-newport News |
| Doing Business As | Rai Care Centers Of Virginia I, Llc |
| Address | 225 Chesapeake Ave Newport News, Virginia, 23607 |
| Phone Number | (757) 928-8044 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
New research indicates that harm from medicines is common in older adults following hospital discharge, and it results in substantial use of healthcare resources.
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 36 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 17 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
New research indicates that harm from medicines is common in older adults following hospital discharge, and it results in substantial use of healthcare resources.
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 54 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 481 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
New research indicates that harm from medicines is common in older adults following hospital discharge, and it results in substantial use of healthcare resources.
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at RAI - Chesapeake-Newport News with elevated calcium levels.
| Patients with hypercalcemia | 55 |
| Hypercalcemia patient months | 488 |
| Patients with Serumphosphor | 61 |
| Patients with Serumphosphor less than 3.5 mg/dL | 14 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 28 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 26 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 20 |
| Patients with Serumphosphor greater than 7 mg/dL | 12 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
New research indicates that harm from medicines is common in older adults following hospital discharge, and it results in substantial use of healthcare resources.
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 47 |
| Patient months included in arterial venous fistula and catheter summaries | 412 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 68 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 11 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
New research indicates that harm from medicines is common in older adults following hospital discharge, and it results in substantial use of healthcare resources.
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 46 |
| Hospitalization Rate in facility | 140.5 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 267.3 |
| Hospitalization Rate: Lower Confidence Limit | 77.2 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
New research indicates that harm from medicines is common in older adults following hospital discharge, and it results in substantial use of healthcare resources.
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at RAI - Chesapeake-Newport News were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 33.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 47.2 |
| Readmission Rate: Lower Confidence Limit | 21.5 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
New research indicates that harm from medicines is common in older adults following hospital discharge, and it results in substantial use of healthcare resources.
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
› Verified 5 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at RAI - Chesapeake-Newport News get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.48 (As Expected) |
| SIR: Upper Confidence Limit | 3.56 |
| SIR: Lower Confidence Limit | .47 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
New research indicates that harm from medicines is common in older adults following hospital discharge, and it results in substantial use of healthcare resources.
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
› Verified 5 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether RAI - Chesapeake-Newport News's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 42 |
| Transfusion Rate in facility | 60.5 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 139.1 |
| Transfusion Rate: Lower Confidence Limit | 29.1 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
New research indicates that harm from medicines is common in older adults following hospital discharge, and it results in substantial use of healthcare resources.
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
› Verified 5 days ago
The rate of mortality show you whether patients who were being treated regularly at RAI - Chesapeake-Newport News lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 218 |
| Mortality Rate in facility | 15.1 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 22.1 |
| Mortality Rate: Lower Confidence Limit | 9.8 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
New research indicates that harm from medicines is common in older adults following hospital discharge, and it results in substantial use of healthcare resources.
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
› Verified 5 days ago
RAI - Thimble Shoals-Newport News Location: 739 Thimble Shoals Blvd, Newport News, Virginia, 23606 Phone: (757) 873-1090 |
Peninsula Dialysis Center Location: 716 Denbigh Blvd, Newport News, Virginia, 23608 Phone: (757) 875-1125 |
RAI - Chesapeake-Newport News Location: 225 Chesapeake Avenue, Newport News, Virginia, 23607 Phone: (757) 247-4080 |
Jefferson Avenue Dialysis Location: 11234 Jefferson Ave, Newport News, Virginia, 23601 Phone: (757) 595-6167 |
News Archive
With infectious diseases increasing worldwide, the need to understand how and why disease outbreaks occur is becoming increasingly important. Looking for answers, a team of University of South Florida biologists and colleagues found broad evidence that supports the controversial 'dilution effect hypothesis,' which suggests that biodiversity limits outbreaks of disease among humans and wildlife.
Topokine Therapeutics has initiated dosing in a Phase 2, randomized controlled clinical trial of XAF5 Gel for reduction of excess submental fat, commonly known as "double chin." XAF5 Gel is a proprietary skin formulation of a compound already known to reduce fat around the human eye. Study participants are applying XAF5 Gel or placebo once a night to skin under the chin.
New research indicates that harm from medicines is common in older adults following hospital discharge, and it results in substantial use of healthcare resources.
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
› Verified 5 days ago